CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-28 | SHERMAN JEFFREY W Director | Sale | −42,232 | $7.92 | $335K | 219,188 |
| 2025-08-28 | SHERMAN JEFFREY W Director | Option exercise · Stock Option (Right to Buy) | −47,040 | 0 | ||
| 2025-08-13 | JOHNSON JOHN Director | Sale | −107,500 | $7.32 | $786K | 833,483 |
| 2025-08-12 | HALKUFF DAWN Director | Sale | −42,500 | $7.28 | $309K | 115,000 |
| 2025-08-01 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −36,918 | $5.38 | $199K | 2,657,425 |
| 2025-08-01 | McCulloch Kevin See Remarks | Shares withheld for taxes | −14,651 | $5.38 | $79K | 1,701,159 |
| 2025-06-13 | McCulloch Kevin See Remarks | Purchase | +25,000 | $4.38 | $109K | 1,708,585 |
| 2025-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award | +50,000 | 157,500 | ||
| 2025-06-04 | PERSKY MARLA Director | Grant or award | +50,000 | 157,500 | ||
| 2025-06-04 | HALKUFF DAWN Director | Grant or award | +50,000 | 157,500 | ||
| 2025-06-04 | SHERMAN JEFFREY W Director | Grant or award | +50,000 | 214,380 | ||
| 2025-06-04 | JOHNSON JOHN Director | Grant or award | +50,000 | 940,983 | ||
| 2025-06-04 | Kong Garheng Director | Grant or award | +50,000 | 214,144 | ||
| 2025-04-02 | McCulloch Kevin See Remarks | Shares withheld for taxes | −733 | $5.15 | $4K | 1,683,585 |
| 2025-03-28 | Brady James Aloysius Director | Grant or award | +100,000 | 100,000 | ||
| 2025-03-20 | Hecht Beth See Remarks | Sale | −40,000 | $5.43 | $217K | 1,353,510 |
| 2025-01-31 | McCulloch Kevin See Remarks | Shares withheld for taxes | −29,300 | $3.56 | $104K | 1,548,152 |
| 2025-01-31 | McCulloch Kevin See Remarks | Shares withheld for taxes | −48,834 | $3.56 | $174K | 1,499,318 |
| 2025-01-31 | McCulloch Kevin See Remarks | Grant or award | +185,000 | 1,684,318 | ||
| 2025-01-31 | McCulloch Kevin See Remarks | Grant or award · Stock Appreciation Right | +500,000 | 500,000 |
Page 6 of 10 · 200 trades